Inactive Instrument

Highlights Voluntis S.A.

Equities

ALVTX

FR0004183960

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

AptarGroup, Inc. completed the acquisition of remaining 35.4% stake in Voluntis S.A..	21-10-14	CI
Global markets live: Intel, Apple, Rolls-Royce, Raytheon, MGM...	21-09-27
Global markets live: Thales, Nestlé, Evergrande, AMC, Walmart...	21-09-16
Global markets live: Amazon, Delivery Hero, Walmart, Broadcom, JD.com, Didi Global...	21-09-03
AptarGroup : Completes Deal to Buy Nearly 65% of Voluntis; Mandatory Takeover Offer to Commence	21-09-03	MT
AptarGroup : Completes Acquisition of Majority Stake in Voluntis	21-09-02	MT
AptarGroup, Inc. made an offer to acquire remaining 35.4% stake in Voluntis S.A. for €27.4 million.	21-09-01	CI
AptarGroup, Inc. completed the acquisition of 64.6% stake in Voluntis S.A. from Vesalius Biocapital Partners S.à r.l, LBO France, Sham Innovation Santé, Bpifrance Participations SA, Debiopharm Innovation Fund SA and Eric Carreel.	21-09-01	CI
AptarGroup : Signs Deal to Buy Majority Stake in Digital Therapeutics Firm Voluntis for 8.70 Euros Per Share	21-07-26	MT
AptarGroup, Inc. signed a share purchase agreement to acquire 64.6% stake in Voluntis S.A. from Vesalius Biocapital Partners S.à r.l, LBO France, Sham Innovation Santé, Bpifrance Participations SA, Debiopharm Innovation Fund SA and Eric Carreel for €50.1 million.	21-07-22	CI
Linklaters Advises Aptar on Entering into Exclusive Negotiations Regarding A Potential Acquisition of Voluntis	21-06-30	CI
Voluntis Enters into Exclusive Negotiations with AptarGroup	21-06-22	CI
AptarGroup : Says in Exclusive Negotiations on Potential Acquisition of Voluntis	21-06-22	MT
Global markets live: Uber, AB Inbev, PayPal...	21-05-06
Voluntis and Eisai to Collaborate on Digital Therapeutics for Oncology Patients	21-04-27	CI
Voluntis S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Broward Health and Voluntis Launch A New Clinical Evaluation Program on Digital Therapeutics for Metastatic Breast Cancer	21-03-18	CI
Voluntis : Changes Listing to Euronext Growth Paris From Euronext Paris	21-02-17	MT
Voluntis : Rises 5% on Receipt of European Patent for Drug Dosing Support Technology	21-02-15	MT
Voluntis : To Change Listing To Euronext Growth Paris; Shares Up 10%	21-02-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Voluntis S.A.

Equities

ALVTX

FR0004183960

Highlights

Filters